Projects per year
Personal profile
Research interests
Health Sciences - Traditional Chinese herbal medicine
Health Sciences - Pharmacological basis of Yang / Qi and Yin / blood Chinese tonifying herbs
Health Sciences - Pharmacological basis of Yang / Qi and Yin / blood Chinese tonifying herbs
Position Held
Associate Director of Center for Chinese Medicine Research and Development
Related documents
Education/Academic qualification
PhD in Pharmacology, PhD, University of British Columbia
1990
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 15 Life on Land -
SDG 17 Partnerships for the Goals
Fingerprint
Dive into the research topics where Robert Kam Ming KO is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
Impedance-Activated Mitochondria Sorter Driven by Machine Learning
KO, R. K. M. (CoI) & YOBAS, L. (PI)
1/01/26 → 31/12/28
Project: Research
-
Phytochemical Extracts Do Not Exhibit the Characteristic Pharmacological Properties of Chinese Tonifying Herbs
KO, R. K. M. & LEUNG, H. Y., Mar 2026, In: Chinese Medicine. 17, 1, p. 8-20 12 p.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
Schisandra Chinensis Fructus (Bei Wuweizi), rather than Schisandra Sphenanthera Fructus (Nan Wuweizi), is responsible for producing the Qi-invigorating effects in the five visceral organs
KO, R. K. M. & LEUNG, H. Y., Mar 2026, In: Chinese Medicine. 17, 1, p. 21-29 8 p.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
Schisandrin B preparation: [United States]
KO, R. K. M. (Key Inventor), 25 Jan 2007, IPC No. A61K 36/79, Patent No. 7276257, 22 Jul 2005, Priority date 22 Jul 2005Research output: Patent
-
Schisandrin B Preparation: [United States]
KO, R. K. M. (Key Inventor), 16 Aug 2007, IPC No. A61K 36/76, Patent No. 7396544, 4 Apr 2007, Priority date 22 Jul 2005, Priority No. US11/188,021Research output: Patent
-
An utimate approach to retarding the aging process by integrating traditional Chinese medicine and Western medicine
Ko, R. K. M. & Leung, H. Y., Aug 2024, In: Chinese Medicine. v. 15, p. 35-48Research output: Contribution to journal › Journal Article › peer-review
Activities
- 1 Editorial work
-
Journal of Complementary and Integrative Medicine (Journal)
KO, K. M. (Editor)
1 Sept 2007 → …Activity: Publication peer-review and editorial work › Editorial work